LLY

784.56

-0.86%↓

JNJ

150.85

-0.97%↓

NVO

74.09

-0.39%↓

ABBV

185.38

+0.09%↑

UNH

307.09

-0.49%↓

LLY

784.56

-0.86%↓

JNJ

150.85

-0.97%↓

NVO

74.09

-0.39%↓

ABBV

185.38

+0.09%↑

UNH

307.09

-0.49%↓

LLY

784.56

-0.86%↓

JNJ

150.85

-0.97%↓

NVO

74.09

-0.39%↓

ABBV

185.38

+0.09%↑

UNH

307.09

-0.49%↓

LLY

784.56

-0.86%↓

JNJ

150.85

-0.97%↓

NVO

74.09

-0.39%↓

ABBV

185.38

+0.09%↑

UNH

307.09

-0.49%↓

LLY

784.56

-0.86%↓

JNJ

150.85

-0.97%↓

NVO

74.09

-0.39%↓

ABBV

185.38

+0.09%↑

UNH

307.09

-0.49%↓

Search

Atara Biotherapeutics Inc

Open

SectorHealthcare

7.99 3.5

Overview

Share price change

24h

Current

Min

7.75

Max

8.03

Recommendations

By TipRanks

Recommendations

Buy

12 Months Forecast

+117.95% upside

Dividends

By Dow Jones

Next Earnings

8 Aug 2025

News Sentiment

By Acuity

50%

50%

170 / 381 Healthcare

Technical Score

By Trading Central

Confidence

Weak Bearish Evidence

Atara Biotherapeutics Inc Chart

Past performance is not a reliable indicator of future results.

Related News

7 Mar 2025, 21:54 UTC

Earnings

Atara Biotherapeutics to Cut Half of Workforce Amid Restructuring

16 Jan 2025, 16:17 UTC

Major Market Movers

Atara Shares Sink After FDA Stalls Cancer Treatment

16 Jan 2025, 14:31 UTC

Major Market Movers

FDA Rejects Atara's Request to Bring Blood Cancer Treatment to Market

Peer Comparison

Price change

Atara Biotherapeutics Inc Forecast

Price Target

By TipRanks

117.95% upside

12 Months Forecast

Average 17 USD  117.95%

High 17 USD

Low 17 USD

Based on 1 Wall Street analysts offering 12 month price targets forAtara Biotherapeutics Inc - Dist in the last 3 months.

Rating Consensus

By TipRanks

Buy

1 ratings

1

Buy

0

Hold

0

Sell

Technical Score

By Trading Central

7.245 / 7.64Support & Resistance

Short Term

Weak Bearish Evidence

Intermediate Term

Strong Bullish Evidence

Long Term

Bearish Evidence

Sentiment

By Acuity

170 / 381 Healthcare

News Sentiment

Neutral

Volatility

Below average

News Volume (RCV)

Below average

Financials

$